Clinical Trials Logo

Facial Hyperpigmentation clinical trials

View clinical trials related to Facial Hyperpigmentation.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03926845 Completed - Clinical trials for Facial Hyperpigmentation

Efficacy and Tolerability of an Isobutylamido-thiazolyl-resorcinol Cream 0.2% for Facial Hyperpigmentation

Start date: April 29, 2019
Phase: N/A
Study type: Interventional

Facial hyperpigmentation is a common skin issue that can cause embarrassment and affect the quality of life in majority of people. The investigators are conducting a research to study an efficacy and tolerability of Isobutylamido-thiazolyl-resorcinol 0.2% in lightening of the facial hyperpigmentation in comparison to vehicle intervention in 4, 8 and 12-week period. The ultimate goal is to provide the best cosmetic cream to improve the quality of life of people who suffer from facial hyperpigmentation.